首页 | 本学科首页   官方微博 | 高级检索  
     


No effects of a 6-week intervention with a glucagon-like peptide-1 receptor agonist on pancreatic volume and oedema in obese men without diabetes
Authors:Maria S. Svane PhD  Helle H. Johannesen MD  Christoffer Martinussen PhD  Kirstine N. Bojsen-Møller PhD  Martin Lundsgaard Hansen PhD  Adam E. Hansen PhD  Carolyn F. Deacon DMSci  Bolette Hartmann PhD  Sune H. Keller PhD  Thomas L. Klausen MSc  Annika Loft PhD  Andreas Kjaer DMSci  Sten Madsbad DMSci  Johan Löfgren MD  Jens J. Holst DMSci  Nicolai J. Wewer Albrechtsen PhD
Affiliation:1. Department of Endocrinology, Hvidovre Hospital, Hvidovre, Denmark

Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;2. Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark;3. Department of Radiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark;4. Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;5. Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;6. Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;7. Department of Endocrinology, Hvidovre Hospital, Hvidovre, Denmark;8. Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Abstract:
Keywords:antiobesity drug clinical trial GLP-1 analogue
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号